Stockscreener 앱 받기
99.29
0.02%
-0.02
시간 외 거래:
99.29
Amedisys Inc 주식(AMED)의 최신 뉴스
Amedisys, Inc. Reports Strong Q2 2025 Revenue Growth - TipRanks
Returns On Capital At Amedisys (NASDAQ:AMED) Have Hit The Brakes - 富途牛牛
Amedisys: Thoughts On UnitedHealth Merger, Plus Underlying Factors - Seeking Alpha
How does Amedisys Inc. generate profit in a changing economyMassive profits - Jammu Links News
How strong is Amedisys Inc. company’s balance sheetExplosive portfolio gains - Jammu Links News
What institutional investors are buying Amedisys Inc. stockAchieve superior returns through strategic trading - Jammu Links News
What are analysts’ price targets for Amedisys Inc. in the next 12 monthsAchieve consistent returns with proven methods - Jammu Links News
How volatile is Amedisys Inc. stock compared to the marketHigh-performance investment picks - Jammu Links News
How does Amedisys Inc. compare to its industry peersExponentially increasing returns - Jammu Links News
What catalysts could drive Amedisys Inc. stock higher in 2025Rapid growth opportunities - Jammu Links News
Should I hold or sell Amedisys Inc. stock in 2025Unlock exclusive stock market forecasts - Jammu Links News
What is the dividend policy of Amedisys Inc. stockStay ahead with advanced stock screening tools - Jammu Links News
What makes Amedisys Inc. stock price move sharplyInvest smarter with daily stock recommendations - Jammu Links News
Why is Amedisys Inc. stock attracting strong analyst attentionMaximize returns with disciplined trading approaches - Jammu Links News
What are the latest earnings results for Amedisys Inc.Rapid portfolio appreciation - Jammu Links News
When is Amedisys Inc. stock expected to show significant growthAchieve rapid portfolio growth with expert help - Jammu Links News
What markets is ELWS expanding into Is Amedisys Inc. stock a good long term investment optionUnlock daily market insights for better decisions - Jammu Links News
Amedisys (AMED) is a Top-Ranked Value Stock: Should You Buy? - Yahoo Finance
Real time pattern detection on Amedisys Inc. stockFast Exit and Entry Strategy Guide Offered - metal.it
Amedisys Exceeds Q2 Revenue Expectations with Strong Financial Profile - AInvest
Amedisys Receives Hold Rating from William Blair; Analyst Consensus Remains Hold - AInvest
Amedisys (AMED) Q2 Revenue Tops 5% - The Globe and Mail
Amedisys (AMED) Q2 Revenue Tops 5% - The Motley Fool
Amedisys Reports Q2 2025 Financial Results Amid Merger - The Globe and Mail
As Mediation Nears, Amedisys Delivers Strong Q2, Charts Impact From Proposed CMS Payment Cut - Home Health Care News
Amedisys stock hits 52-week high at 98.63 USD - Investing.com Australia
Amedisys stock hits 52-week high at 98.63 USD By Investing.com - Investing.com South Africa
How Investors Are Reacting To Amedisys (AMED) Rebound in Year-to-Date Earnings Amid Quarterly Decline - simplywall.st
Amedisys Sees Hospice Revenue Rise Amid DOJ’s UnitedHealth Group Acquisition Lawsuit - Hospice News
AMEDISYS INC SEC 10-Q Report - TradingView
Amedisys Inc. Volume Confirms Breakout — Analysts BullishAI Forecast for Trending Stocks Indicates Upside - beatles.ru
Amedisys 2025 Q2 Earnings Record High Net Income Despite Decline - AInvest
Amedisys: Q2 Earnings Snapshot - Huron Daily Tribune
Amedisys (AMED) Q2 2025 Earnings: Resilience Amid Merger Costs and Industry Consolidation - AInvest
Amedisys (AMED) Q2 Earnings Beat: A Strategic Buy Opportunity Amid Merger Uncertainty? - AInvest
Here's What Key Metrics Tell Us About Amedisys (AMED) Q2 Earnings - Nasdaq
Amedisys (AMED) Beats Q2 Earnings and Revenue Estimates - Yahoo Finance
Amedisys Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Amedisys earnings beat by $0.18, revenue topped estimates - Investing.com Canada
Amedisys Outpaces Expectations With Strong Q2 Results - Finimize
Amedisys Reports Second Quarter 2025 Financial Results - The Globe and Mail
Amedisys Reports Retreat In Q2 Profit - Nasdaq
Amedisys, Inc. Reports Q2 2025 Financial Results with Increased Revenue Despite Merger-Related Expenses - Quiver Quantitative
TFI International Reports Decline in Q2 2025 Revenue and Income - The Globe and Mail
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of August 29, 2025 in Petco Health and Wellness Company, Inc. LawsuitWOOF - The Globe and Mail
0.68%
0.19%
자본화:
|
볼륨(24시간):